What Fueled The Previous Growth In The Breast Tissue Markers Market?
The breast tissue markers market has seen considerable growth due to a variety of factors.
• The market size of breast tissue markers has experienced robust growth in the previous years. It estimates that it will increase from $2.75 billion in 2024 to $2.99 billion in 2025, showcasing a compound annual growth rate (CAGR) of 8.5%.
Factors contributing to this growth during the historic period can be linked to advancements in imaging technology, the expansion of breast cancer screening programs, advancements in minimally invasive biopsy techniques, regulatory endorsements and standardization, along with the preferences of surgeons and radiologists.
What Is The Expected Growth In The Breast Tissue Markers Market Size Evolve over the Forecast Period?
The breast tissue markers market is expected to maintain its strong growth trajectory in upcoming years.
• The market for breast tissue markers is predicted to exhibit robust growth in the coming years, reaching $4.1 billion by 2029, propelled at a Compound Annual Growth Rate (CAGR) of 8.3%.
Factors fueling this estimated growth in the forecast period include the rising acceptance of personalized medicine, the surging demand for minimally invasive operations, the evolution of outpatient and ambulatory surgery centers, growing healthcare spending, as well as insurance coverage, and the incorporation of artificial intelligence. Emerging trends during this forecast period include the escalating adoption of biodegradable breast tissue markers, partnerships with advanced imaging technologies, emphasis on patient comfort, sustainability, and environmentally friendly products, alliances between diagnostic and therapeutic systems, and the use of wireless and remote monitoring.
What Main Forces Are Fueling Expansion In The Breast Tissue Markers Market?
The escalation in breast cancer incidences is anticipated to fuel the expansion of the breast tissue markers market. Breast cancer begins as a malignant tumor in the cells of the breast. Increased lifespan, enhanced detection procedures, alterations in lifestyle, and environmental impacts are typically associated with the surge in breast cancer cases. Breast tissue markers play a pivotal role in diagnosing breast cancer, monitoring its advancement, and determining appropriate treatment by detecting distinctive proteins or genetic aberrations. To exemplify, the American Cancer Society, a USA-based entity, reported that in January 2023 the count of fresh invasive breast cancer occurrences in American women jumped from roughly 281,550 in 2021 to 297,790 in 2023. Concurrently, the number of instances among males escalated from 2,650 to 2,800 during the identical span. Hence, the surge in breast cancer occurrences is accelerating the expansion of the breast tissue markers market.
What Are The Primary Segments In The Global Breast Tissue Markers Market?
The breast tissue markersmarket covered in this report is segmented –
1) By Product: Metal, Non-metal
2) By Material: Non-biodegradable, Partially Biodegradable
3) By Shape: Coil, Ribbon, Butterfly, V-Shape, Other Shapes
4) By End-user: Hospitals, Ambulatory, Surgical Centers, Diagnostic Centers, Specialty Clinics
Subsegments:
1) By Metal Tissue Markers: Titanium Markers, Stainless Steel Markers, Gold Markers
2) By Non-Metal Tissue Markers: Biodegradable Markers, Radiopaque Markers, Polymer-Based Markers, Gelatin Markers
Pre-Book The Breast Tissue Markers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Breast Tissue Markers Market?
Leading entities in the breast tissue markers industry are concentrating on the creation of novel solutions like breast biopsy site markers to improve ultrasound visibility, simplify location tracking, and lessen the movement during surgery. A breast biopsy site marker is a tiny tool positioned at the biopsy site to denote the location for future imaging or surgical processes. For instance, in August 2023, Mammotome, a company based in the US that specializes in breast biopsy markers, launched the HydroMARK Plus breast biopsy site marker. This marker is characterized by its hydrogel design that expands upon coming into contact with fluid, thus increasing its visibility in ultrasound images. The creative design offers exact site marking and accurate pinpointing for future diagnostic and treatment procedures. It also promises long-term steadiness within the breast tissue, thereby reducing the need for additional interventions.
Who Are the Key Players In The Breast Tissue Markers Market?
Major companies operating in the breast tissue markers market are:
• Johnson & Johnson Company
• Thermo Fisher Scientific
• Medtronic PLC
• Siemens Healthineers
• Stryker Corporation
• GE HealthCare Technologies Inc.
• Hologic Inc.
• Kaiser Permanente
• Cook Medical Inc.
• Merit Medical Systems Inc.
• Leica Biosystems Inc.
• Argon Medical Devices Inc.
• Devicor Medical Products Inc.
• Mermaid Medical Group
• iCAD Inc.
• Endomag
• Focal Therapeutics Inc.
• Laurane Medical
• Carbon Medical Technologies Inc.
• Becton Dickinson and Company
• INRAD Inc.
• Izi Medical Products LLC
• Sanarus Technologies Inc.
• Scion Medical Technologies LLC
• Biopsy Sciences LLC
What Is The Most Dominant Region In The Breast Tissue Markers Market?
North America was the largest region in the breast tissue markers market in 2024. The regions covered in the breast tissue markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
